Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia. [electronic resource]
Producer: 20060912Description: 203-9 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Burkitt Lymphoma -- therapy
- Chi-Square Distribution
- Female
- Graft vs Host Disease -- prevention & control
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Immunologic Factors -- therapeutic use
- Middle Aged
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- therapy
- Rituximab
- Statistics, Nonparametric
- Survival Analysis
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.